Author： Lappas Panos T Rose Peter G
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.9, 2002-09, pp. : 1245-1249
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Khrunin Andrey Ivanova Feodosia Moisseev Alexey Khokhrin Denis Sleptsova Yuliya Gorbunova Vera Limborska Svetlana
Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. :
Access to resources
Recommend
Cisplatin-based adjuvant therapy improves survival in NSCLC
Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. :
A Review of the Pharmacoeconomics of Pharmaceutical Care
By Plumridge R.J. Wojnar-Horton R.E.
PharmacoEconomics, Vol. 14, Iss. 2, 1998-08 ,pp. :
Cisplatin plus paclitaxel superior in cervical cancer?
Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. :